Founded by Olek Shestakov and Alex Aprelev, OxyDial develops an Oxygen-Hemoglobin Equilibrium blood-testing instrument and cloud platform for medical researchers and healthcare providers. The company’s work is aimed particularly at improving understanding and care for sickle cell disease and other blood disorders, with the instrument and services still under development and testing and not yet FDA-approved. Its founders bring more than 25 years of experience spanning software architecture, wearables, IoT devices, optics and spectroscopy.